THAR · Tharimmune

Tharimmune, Inc. focuses on leveraging Canton Coin and supporting the Canton network to advance institutional blockchain adoption and the digitization of financial markets. It is also involved in the clinical-stage biotech research and development activities. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was founded in 2017 and is based in Red Bank, New Jersey.

34 Shrewsbury Avenue, Red Bank, NJ, 07701, United States
Biotechnology
Healthcare

Market Cap

187.4M

52 Wk Range

$0.95 - $9.08

Previous Close

$2.24

Open

$2.24

Volume

467,844

Day Range

$2.24 - $2.37

Enterprise Value

191.4M

Cash

17.03M

Avg Qtr Burn

-10.44M

Insider Ownership

22.66%

Institutional Own.

22.24%

Qtr Updated

Dec 31st 2025